71 results
8-K
PLSE
Pulse Biosciences, Inc.
15 Jul 24
Entry into a Material Definitive Agreement
7:10am
preliminary financial results included in this Current Report on Form 8-K have been prepared by and are the responsibility of the Company’s management
8-K
EX-1.1
PLSE
Pulse Biosciences, Inc.
15 Jul 24
Entry into a Material Definitive Agreement
7:10am
or fiduciary responsibility in favor of the Company with respect to the offering contemplated hereby or the process leading thereto (irrespective of whether
424B5
PLSE
Pulse Biosciences, Inc.
15 Jul 24
Prospectus supplement for primary offering
7:04am
supplement. We and the Agents do not take responsibility for, and can provide no assurance as to the reliability of, any other information that others may … in this prospectus supplement have been prepared by and are the responsibility of our management. Our independent registered public accounting firm
424B2
PLSE
Pulse Biosciences, Inc.
4 Jun 24
Prospectus for primary offering
4:05pm
those contained in this prospectus or any applicable prospectus supplement. We do not take responsibility for, and can provide no assurance
POS AM
wb593kk4
28 May 24
Prospectus update (post-effective amendment)
5:19pm
8-K
kbysi6x
15 May 24
Pulse Biosciences Enhances Executive Leadership Team
9:05am
8-K
EX-99.1
hnodk3dlleztcprc
15 May 24
Pulse Biosciences Enhances Executive Leadership Team
9:05am
8-K
EX-10.2
0it6k209iefobit
15 May 24
Pulse Biosciences Enhances Executive Leadership Team
9:05am
8-K
EX-10.3
it8lzo2uxc9 c9y
15 May 24
Pulse Biosciences Enhances Executive Leadership Team
9:05am